University of Missouri-Columbia
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Missouri-Columbia sits in the top decile of US sponsors by registered trial count (#120 of 15,742 sponsors by registered trial count).
University of Missouri-Columbia: 291 sponsored US clinical trials, 54 recruiting.
University of Missouri-Columbia sponsors 291 registered US clinical trials on ClinicalTrials.gov, 54 of them currently recruiting, and 170 completed. 29 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
University of Missouri-Columbia ranks in the top decile of sponsors by registered trial count (#120 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
170 of 224 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
291 total, page 3 of 6
Experience With a Pediatric Summer Intensive Therapy Program
NCT04891328
Resistance Training Effects on Gut Microbiome and Cardiometabolic Outcomes
NCT04906525
Screening for Sacral Agenesis in Offspring of Mothers With Diabetes in Pregnancy
NCT05033275
A Randomized Trial of Exparel vs Saline in Opioid Reduction of Pain Management Following Lumbar Spine Surgeries.
NCT04644796
n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy
NCT05145452
Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation
NCT03523520
Effects of a Personalized Diet on Cardiometabolic, Microbiome and Metabolomics Profiles in Minority Young Adults
NCT04635917
Use of Traditional Curved Iris Scissors or the Wuennenberg Modified Curved Iris Scissors for Skin Surgery
NCT04413383
Remote Neurocognitive and Psychological Assessment in PKU
NCT04943393
Comparison and Outcomes of Endoscopic Ultrasound Liver Biopsies Versus Percutaneous Liver Biopsies
NCT04751045
Feasibility Testing of Cognitive Strategy Training in Post-Concussive Syndrome
NCT04681742
Topical Tranexamic Acid Use on Granulating Wounds Following Mohs Micrographic Surgery
NCT04541303
Open Label Study: Treatment of ALS Fatigue With PolyMVA
NCT04557410
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
NCT05219994
Endovascular Stroke Treatment Only (ESTO) Trial
NCT04240470
Local Infiltration Analgesia Vs. Interscalene Block in Total Shoulder Arthorplasty
NCT04415931
Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction
NCT05244694
Bupivacaine for Post-operative Pain in Mohs
NCT04362566
Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
NCT04402970
Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study
NCT04421690
Perioperative Pregabalin in Ureteroscopy
NCT04122196
Feasibility Trial of an Online Course (eMB) to Reduce Anxiety and Depression for Pregnant Women and Their Partners
NCT05867680
Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth
NCT04385901
COVID-19 in Patients With HIV
NCT04333953
Playing Cognitive Games For Older Adults With Insomnia
NCT04282642
RTLS for Healthcare Process Validation
NCT04116957
Surgical Weight Loss and Alcohol Perception
NCT04299373
tDCS and CO-OP in Chronic Stroke
NCT04617548
Metacognitive-Strategy Training in Sub-Acute Stroke
NCT04099511
Impact of Exercise on Diastasis Rectus Abdominus
NCT04049487
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
NCT03960138
Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder
NCT04076644
CBT-I on Alcohol Treatment Outcomes Among Veterans
NCT03806491
ENAC Blockade and Arterial Stiffness
NCT03837626
Ketogenic Diet for Traumatic Brain Injury
NCT03982602
The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries
NCT03812991
Differential Efficacy of Corticosteroid Solutions for Non-Operative Treatment of Digit Flexor Tenosynovitis
NCT04002037
Non-operative vs Surgical Treatment of Isolated Non-Thumb Metacarpal Shaft Fractures
NCT04001062
Feasibility of Better Living After Stroke Through Technology
NCT03935789
Weight Stigma Effect on Neural Control of Appetite
NCT03934424
The iTAP Study for Veterans
NCT03804788
Perioperative Pregabalin in Ureteroscopy: a Pilot
NCT03927781
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
NCT03824808
Sleep and Pain Interventions in Women With Fibromyalgia
NCT03744156
De Novo Lipogenesis in Severity of NAFLD
NCT03683589
The Effect of Kombucha on Blood Sugar Levels in Humans
NCT04051294
Effect of NSAID Use on Pain and Opioid Consumption Following Distal Radius Fracture
NCT03749616
Indications for Osteochondral Allograft Transplantation
NCT03711747
Hyperosmolar Saline Irrigation Fluid in Arthroscopic Knee Surgery
NCT03564886
Alcohol Impaired Driving: From the Laboratory to the Natural Environment
NCT03846050
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 26 |
| Phase 2 | 12 |
| Phase 3 | 4 |
| Phase 4 | 25 |
Therapeutic Areas
What is open in the University of Missouri-Columbia pipeline
54 recruiting of 291 indexed (19% open); 170 completed (58%).
Phase mix: 29 late (III/IV) vs 38 early (I/II) (balanced across stages).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Missouri-Columbia: open-pipeline peers nationwide
Peers matched on 291 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Missouri-Columbia sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 291 trials (± recruiting share)
- Thomas Jefferson University · 292 trials · 18% recruiting
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- Kaiser Permanente · 294 trials · 7% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
- Montefiore Medical Center · 19% recruiting · 345 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Mclean Hospital · 19% recruiting · 140 trials
Related
What to do with this University of Missouri-Columbia page
291 registered trials is a research-attention snapshot, not an endorsement of University of Missouri-Columbia or any single study.
- 54 of University of Missouri-Columbia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Missouri-Columbia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Missouri-Columbia pipeline card: 291 registered trials from official public datasets.Report a data error.